Billionaire Stanley Druckenmiller’s Top Value Picks Include Illumina, Inc. (ILMN), Biogen Inc (BIIB), LyondellBasell Industries NV (LYB)

We move next onto Stanley Druckenmiller’s investment in the global biotechnology company, Biogen Inc (NASDAQ:BIIB), one of the top biotech stocks among billionaires as a whole. Founded in 1978, the company discovers, develops and provides to customers innovative therapies for the treatment of neurodegenerative diseases, autoimmune disorders and hemophilia. During the January-March period, Duquesne Capital Management LLC cut its position in Biogen Inc (NASDAQ:BIIB) by 51.31% to 175,000 shares, valued at $73.89 million. In recent days, Biogen Inc (NASDAQ:BIIB) announced that it intends to repurchase up to $5 billion of its common stock, within a period of up to five years. Biogen Inc (NASDAQ:BIIB)’s stock gained 16.49% year-to-date and is up by 35.73% over the last 52 weeks. Samuel Isaly’s Orbimed Advisors and D E Shaw are among the largest investors that own substantial positions in the company as of the end of the first quarter of 2015, holding 1.21 million shares and 912,933 shares, respectively.

Duquesne Capital initiated a new position in LyondellBasell Industries NV (NYSE:LYB) consisting of 716,950 shares valued at $62.95 million, which represents 7.99% of its portfolio. LyondellBasell Industries NV (NYSE:LYB), with a $49.4 billion market cap, is one the world’s leading plastics, chemicals and refining companies. Its products are widely used in construction materials, electronics, automotive components, medical supplies and other domains. For the first quarter of 2015 the chemical company showed an increase in net income of 47.16% to $1.16 million, or $2.41 diluted earnings per share, compared to the same period of 2014. LyondellBasell Industries NV (NYSE:LYB) repurchased 15.7 million shares valued at $1.69 billion, which represents more than 3% of its outstanding shares. Other funds that have large positions in LyondellBasell Industries NV (NYSE:LYB) include Viking Global managed by Andreas Halvorsen with 7.71 million shares, followed by Zach Schreiber’s Point State Capital and the quant fund D. E. Shaw, with 5.96 million shares and 4.98 million shares, respectively.

Disclosure: None